[IPp] Spleen may be source of versatile stem cells
- To: Rachel A <email @ redacted>
- Subject: [IPp] Spleen may be source of versatile stem cells
- From: Rachel A <email @ redacted>
- Date: Thu, 20 Jan 2005 13:28:37 -0800 (PST)
- Comment: DomainKeys? See http://antispam.yahoo.com/domainkeys
- Reply-To: email @ redacted
Remember this from a year or so
be source of versatile stem cellsCells have protein associated with embryonic
development, limb regenerationA year ago, Massachusetts General Hospital (MGH)
researchers discovered that the spleen might be a source of adult stem cells
that could regenerate the insulin-producing islets of the pancreas. In a
follow-up to that unexpected finding, members of the same team now report that
these potential adult stem cells produce a protein previously believed to be
present only during the embryonic development of mammals.
The finding both supports the existence of these splenic stem cells and also
suggests they may be able to produce an even greater variety of tissues. The
report appears in the January 19 issue of SAGE KE (http://sageke.sciencemag.org
), an online resource on the science of aging from the publishers of the journal
"There may be a previously undiscovered pocket of primitive stem cells in the
spleen that are important for healing several types of damage or injury," says
Denise Faustman, MD, PhD, director of the MGH Immunobiology Laboratory and
senior author of the SAGE KE report. "If so, these cells could have much broader
therapeutic applications than suggested by our earlier work."
In 2001 Faustman's team found that a treatment designed to address the
autoimmune reaction underlying type 1 diabetes actually cured the disease in
diabetic mice. Late in 2003 they reported the mechanism behind the earlier
discovery: cells from the spleens of donor mice intended to train the diabetic
animals' immune systems not to attack islet cells were actually producing new
islets. The result suggested that the adult spleen previously regarded as
playing a fairly minor role in regenerative medicine might contain a
population of potential islet stem cells.
In their pursuit of that finding, the MGH researchers investigated the possible
presence of a protein called Hox11 in these cells. In mammals, Hox11 is a
controller of key steps in embryonic development including the formation of
the spleen but it was not known to be present in adults under normal
circumstances. In some other animals, however, the protein has an intriguing
function: when creatures like newts regenerate a lost limb or tail, production
of Hox11 is radically increased.
As reported in their SAGE KE article, the MGH team did find that Hox11 was
produced in the spleens of adult mice by the same cells that regenerated the
islets in the earlier study. They also found that these cells did not produce a
protein known to be associated with a cellular commitment to develop into a
particular type of tissue. Without that commitment, the splenic cells may be
able to differentiate into a wider variety of cells than can adult stem cells
from bone marrow, which do not produce Hox11.
The researchers also note that the spleen develops from embryonic tissue that
is known not only to generate precursors to many types of blood cells, a
function shared by the bone marrow, but potentially to form such diverse organs
as the small intestine, uterus, vascular system and lung. They theorize that a
pocket of these uncommitted cells might remain in the spleen though adulthood.
In addition to regeneration of islets, these cells might also produce bone cells
suggested by findings from other researchers or potentially even cells of
the nervous system, development of which depends on the correct production of
"We know that if you have a major loss of blood, the spleen is turned on to
supplement the bone marrow in replenishing your blood supply. We may find that
the spleen kicks in to help with many more biological emergencies. What has been
considered a practically unnecessary organ may actually provide critical healing
cells," says Faustman, an associate professor of Medicine at Harvard Medical
She adds, "This data also shows the kind of payback that can come from studies
of lower animals like newts and sponges. Combining the knowledge of Hox11's role
in those animals with what we'd found about islet cell regeneration in mice
helped us find this previously unknown example of normal, controlled Hox11
expression in an adult mammal."
Co-authors of the SAGE KE report are first author Shohta Kodama, MD, PhD, of
the MGH Immunobiology Laboratory, and Miriam Davis, PhD, of George Washington
University. The group's research is supported by grants from the Iacocca
Foundation. Founder Lee Iacocca is also spearheading an effort to raise money
for a clinical trial of the islet-regeneration technique in human patients. For
more information about this program, go to http://www.joinleenow.org.
Massachusetts General Hospital, established in 1811, is the original and
largest teaching hospital of Harvard Medical School. The MGH conducts the
largest hospital-based research program in the United States, with an annual
research budget of more than $400 million and major research centers in AIDS,
cardiovascular research, cancer, cutaneous biology, medical imaging,
neurodegenerative disorders, transplantation biology and photomedicine. In 1994,
MGH and Brigham and Women's Hospital joined to form Partners HealthCare System,
an integrated health care delivery system comprising the two academic medical
centers, specialty and community hospitals, a network of physician groups, and
nonacute and home health services.
Rachel - "I would rather live my life as if there is a God, and die to find out
there isn't, than live my life as if there isn't, and die to find out there is."
Do you Yahoo!?
Yahoo! Search presents - Jib Jab's 'Second Term'
for HELP or to subscribe/unsubscribe/change list versions,